Note 14 - Segment Information

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

14.   SEGMENT INFORMATION

The Company follows ASC280, “Segment Reporting,” which establishes standards for companies to report information about operating segments, geographic areas and major customers. The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note 1 to the Company’s Consolidated Financial Statements).

Segment operating income (loss) includes selling, general and administrative expenses directly attributable to that segment as well as charges for allocating corporate costs to each of the operating segments. The following tables reflect the results of the reportable segments consistent with the Company’s management system:

Fiscal Year Ended December 31, 2022	Specialty Health Care		Engineering			Life Sciences and IT		Corporate		Total
Revenue	$	159,448	$	85,937		$	39,295	$	-	$	284,680
Cost of services		111,543		64,218			25,992		-		201,753
Gross profit		47,905		21,719			13,303		-		82,927
Selling, general and administrative		27,661		17,272			8,462		-		53,395
Depreciation and amortization of property and equipment		426		455			114		-		995
Amortization of acquired intangible assets		-		-			46		-		46
Remeasurement of acquisition-related contingent consideration		-		(88	)		-		-		(88	)
Gain on sale of assets		-		(219	)		-		-		(219	)
Operating income	$	19,818	$	4,299		$	4,681	$	-	$	28,798
Total assets as of December 31, 2022	$	34,062	$	33,447		$	15,778	$	4,677	$	87,964
Property and equipment acquired	$	75	$	657		$	124	$	296	$	1,152

Fiscal Year Ended January 1, 2022	Specialty Health Care		Engineering			Life Sciences and IT		Corporate		Total
Revenue	$	98,495	$	66,172		$	39,208	$	-	$	203,875
Cost of services		73,177		50,109			27,465		-		150,751
Gross profit		25,318		16,063			11,743		-		53,124
Selling, general and administrative		19,491		14,210			8,318		-		42,019
Depreciation and amortization of property and equipment		373		521			113		-		1,007
Amortization of acquired intangible assets		-		95			-		-		95
Remeasurement of acquisition-related contingent consideration		-		(1,713	)		-		-		(1,713	)
Gain on sale of assets		-		(2,420	)		-		-		(2,420	)
Operating income	$	5,454	$	5,370		$	3,312	$	-	$	14,136
Total assets as of January 1, 2022	$	32,809	$	28,343		$	8,676	$	3,024	$	72,852
Property and equipment acquired	$	563	$	481		$	173	$	359	$	1,576

Fiscal Year Ended January 2, 2021	Specialty Health Care			Engineering			Life Sciences and IT			Corporate			Total
Revenue	$	60,481		$	57,715		$	32,213		$	-		$	150,409
Cost of services		47,116			41,227			23,211			-			111,554
Gross profit		13,365			16,488			9,002			-			38,855
Selling, general and administrative		15,601			13,021			9,169			-			37,791
Depreciation and amortization of property and equipment		319			638			108			-			1,065
Amortization of acquired intangible assets		-			321			-			-			321
Write-off of receivables and professional fees incurred related to arbitration		-			8,397			-			-			8,397
Impairment of right of use assets and related costs		-			-			-			2,231			2,231
Operating (loss)	$	(2,555	)	$	(5,889	)	$	(275	)	$	(2,231	)	$	(10,950	)
Total assets as of January 2, 2021	$	19,141		$	33,782		$	7,498		$	7,918		$	68,339
Property and equipment acquired	$	36		$	26		$	48		$	350		$	460

The Company derives a majority of its revenue from offices in the United States. Revenue reported for each operating segment are all from external customers. The Company is domiciled in the United States and its segments operate in the United States, Canada, Puerto Rico and Serbia. Revenue by geographic area for the fiscal years ended December 31, 2022, January 1, 2022 and January 2, 2021 are as follows:

	Fiscal Year Ended
	December 31,		January 1,		January 2,
	2022		2022		2021
Revenue
United States	$	272,342	$	186,169	$	126,238
Canada		4,708		9,578		15,310
Puerto Rico		5,180		5,237		5,702
Serbia		2,630		2,891		3,159
	$	284,680	$	203,875	$	150,409

Total assets by geographic area as of the reported periods are as follows:

	Fiscal Year Ended
	December 31,		January 1,		January 2,
	2022		2022		2021
Total Assets
United States	$	81,558	$	67,296	$	56,308
Canada		1,640		1,327		7,067
Puerto Rico		1,401		963		1,483
Serbia		3,365		3,266		3,481
	$	87,964	$	72,852	$	68,339